Why Diabetic Nerve Pain Burns at Night — and Why the Same Foot Feels Nothing

What this video covers

• How high blood sugar, bad blood fats, and damage to tiny blood vessels are thought to harm the longest nerves first, and why that mechanism is still mostly lab research
• Why small fibers fail first (burning) and large fibers later (numbness, poor balance), and why numb feet need a daily check to prevent ulcers and amputation
• What blood sugar control can and cannot do: it prevents new nerve damage in type 1 diabetes, was not significant in type 2, does not reverse existing damage, and raises the risk of low blood sugar
• What the 2022 American Academy of Neurology guideline recommends, why it advises against opioids, and which drugs it supports
• When 10 kHz spinal cord stimulation fits pain that will not respond, what the randomized data showed, and what the trial did not prove
• MEDICAL DISCLAIMER: This content is for educational purposes only and is not medical advice. It does not substitute for professional diagnosis or treatment. Always consult a licensed healthcare provider regarding your condition. Viewing this video does not establish a doctor-patient relationship.

Diabetic nerve pain burns at night because the small fibers that carry burning and temperature fail first. They fail at the far end of the longest nerves, in the feet. Then a bedsheet is read as an injury. The large fibers that carry touch and position fail later. That is why the same foot can burn and feel nothing.

It starts at night. The sheet touches your toes and it burns. Your socks feel like sandpaper. You put your hand on your feet and the skin tells you nothing. It feels ordinary, sometimes cool. The fire is on the inside, where your hand cannot reach it.

And then there is the part nobody explains. The burning is unbearable, yet you can cross gravel and never feel it. Fierce pain and dead numbness, in the same foot, at the same time. That is not a contradiction. It is a signature. This article explains what is physically happening inside the nerve and why it causes exactly that pair of symptoms. It covers what a fifteen-minute prescription visit tends to miss. And it shows what an honest evaluation looks like.

Why does diabetic neuropathy start in the feet?

Diabetic peripheral neuropathy is a length-dependent, dying-back axonopathy. In plain words: it fails at the far end of the wire first, and it works its way back toward the source.

Think about what your body asks of these cells. Your longest nerve fibers belong to sensory nerve cells whose bodies sit just outside your low back spine. Their fibers run all the way down to your big toe. That is close to a meter of living membrane. One single cell has to build, supply, maintain, and power it from a distance. The far end of that wire is the hardest part to supply. It is the first place to go dark.

That layout also predicts what happens next. When the numbness has climbed to about your knees, your fingertips are next in line. At that point, the remaining leg fiber and the fiber running to your fingertip are about the same length. That is when the hands begin. Doctors call the pattern stocking and glove.

What we know about why the nerve fails — and how confident we are

Here honesty matters. In lab and animal studies, high blood sugar and bad blood fats set off several kinds of damage. These include sugar byproducts, sugar-bonded proteins, oxidative stress, and injury to the vasa nervorum — the tiny blood vessels that feed the nerve itself. That work is still in the lab. It has produced no approved drug that changes the course of diabetic nerve damage in people. It is a picture of the mechanism, not a treatment target you can act on today.

Pain that lasts after blood sugar is well controlled is usually blamed on central sensitization. That is the nervous system turning up signals after long injury. It is a reasonable guess. It is not a measured fact in any one patient.

Why do burning and numbness happen in the same foot?

Your nerves are not one wire. They are bundles of different fiber types. And they do not fail on the same schedule.

Small fibers fail first. These are the bare C fibers and the thinly coated A-delta fibers. They carry burning, temperature, and pinprick. When they break down, you get burning. You also get allodynia — a bedsheet, a harmless thing, read by the nervous system as an injury. That is why bedding is so often the trigger people describe. And it is why the symptom is most often reported at night, when the feet are still and touching the sheet.

Large myelinated fibers fail later. These carry touch, vibration, and joint position sense — the normal sense of where your foot is. When they go, you get numbness, loss of vibration and position sense, and unsteadiness in the dark, when your eyes can no longer make up for what your feet stopped reporting.

The small fibers go first and the large fibers later. So there is a long window when both are failing in the same foot. That is the “burning but numb” experience. It is a known signature of the condition, not an exaggeration on your part.

The numbness also carries the real danger in this condition. A foot that cannot feel a pebble will not report an ulcer until that ulcer is deep. And an unnoticed ulcer is how people lose limbs. Numb feet need to be looked at — every day by you, and at every visit by your doctor. A daily check is how you keep your leg.

What does a prescription-only visit for burning feet miss?

What most people with these feet get is a prescription and a shrug. Gabapentin at 300 mg, then 900, then 1800. When that fails, more.

What frequently does not happen in that same fifteen minutes:

• Nobody checks B12 or thyroid function. Either can cause nerve damage that mimics the diabetic pattern.
• Nobody sends a serum protein electrophoresis with immunofixation to look for an abnormal blood protein. Electrophoresis alone is not enough, because small clones hide from it. That kind of nerve damage looks the same from across the room. But it belongs in a different clinic entirely.
• Nobody asks honestly about alcohol. Nobody checks the low back for a pinched nerve root, which can mimic or join the diabetic pattern.
• Nobody takes your shoes off.

There is one more gap worth naming. When gabapentin fails, the next step offered is too often an opioid. The 2022 American Academy of Neurology guideline advises against that for painful diabetic nerve damage (a Level B recommendation not to use them).¹

None of this criticizes the medicines themselves. Drug therapy has a real place here. The 2022 AAN guideline supports four drug classes for this condition.¹ But they only treat symptoms. The benefit lasts only while you take the drug, and it does nothing for the state of the nerve. The failure is not the prescription. The failure is the workup that never happened around it.

And the thing you were told about blood sugar

You have probably been told that getting your sugar down fixes this. The evidence is narrower than that. It deserves to be stated precisely.

A 2012 Cochrane review — never updated — found that tighter blood sugar control prevents new neuropathy in type 1 diabetes. That was on high-quality evidence. In type 2 diabetes, the drop was not statistically significant. And that evidence is about preventing nerve damage, not reversing damage you already have. The same review found that pushing sugar hard significantly raises severe low blood sugar episodes.²

So blood sugar control is still the only treatment with any evidence that it changes the disease. It is worth pursuing. Aim for a target your diabetes doctor sets for you, not the lowest number you can force. Pushing sugar too low has its own real harms. You deserve to know what blood sugar control buys you and what it does not.

How is diabetic nerve pain in the feet evaluated and treated?

Take your shoes off, because that is where this starts. Nothing gets injected into a spine and nothing gets implanted until two things happen. The stocking pattern on your own feet must be mapped by hand. And the conditions that mimic it must be ruled out on paper.

A real workup includes:

• Confirmed diabetes, and an even pattern on both sides that starts at the far end, found on exam. That means a 10 g monofilament, a 128 Hz tuning fork, pinprick, ankle reflexes, and position sense.
• Electrodiagnostic testing where it changes the answer. One key limit: nerve conduction studies read large fibers. They can be fully normal in pure small-fiber nerve damage.
• A 3 mm skin punch biopsy from the distal leg when the exam says small fiber and the conduction study says normal. It settles the question by counting the nerve fibers in your own skin.
• Exclusion of the mimics: B12 deficiency, thyroid disease, abnormal blood proteins, alcohol, and a pinched nerve root in the low back (radiculopathy).
• Foot inspection at every visit, for the reason described above.

On medications, know which is which. The 2022 AAN guideline offers four classes: tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, and sodium channel blockers. Tricyclics showed the biggest effect — at low confidence. That is worth saying out loud, not burying.¹ Pregabalin, duloxetine, tapentadol extended release, and the 8% capsaicin patch are FDA-approved for this use. Gabapentin, amitriptyline, nortriptyline, venlafaxine, and the sodium channel blockers are fair options with some evidence behind them too. And the uncomfortable part: tapentadol has FDA approval here and a Level B recommendation against it from that same guideline.

The risks are specific. Gabapentinoids need a lower dose when kidneys are weak. They cause sleepiness, ankle swelling, weight gain, and falls, and serious breathing risk alongside other sedatives. Tricyclics affect the heart’s electrical system. So heart history and an ECG come first. They also cause dry mouth and constipation-type effects and drops in blood pressure on standing. Antidepressants and seizure drugs carry warnings about suicidal thoughts. Do not start, stop, or change any medication without consulting your physician.

When pain stays severe after a gabapentinoid plus one other class for a year or longer, high-frequency spinal cord stimulation becomes a fair topic. Under live X-ray, two eight-contact leads are placed through the skin into the epidural space behind the spinal cord. They span the eighth through eleventh mid-back vertebrae, over the nerve tracts that carry feeling from the feet and legs. You do a one-week trial first, with the leads coming out through the skin. If it does not deliver, nothing is implanted and the leads come out. You can read how the procedure is done and staged on our diabetes and neuropathy treatment page.

What the data show, with their limits: a randomized trial was published in JAMA Neurology in 2021. At three months, 79% of people on 10 kHz stimulation plus standard care got at least 50% pain relief without worsening of neurological deficits. That compares with 5% on standard care alone.³ Patients knew which group they were in, and there was no sham. The control group switched over at six months, so anything after that is uncontrolled. To enroll, people needed an HbA1c of 10% or less, a BMI of 45 or less, pain of at least 5 out of 10, and no open foot ulcer. If you do not look like that group, the numbers may not describe you. The FDA approval here is for one device, not the whole class. Individual results vary. These are trial averages, not a promise about your feet.

The risks are real. They include infection that requires removing the device — about 2% in that trial, and more likely with diabetes. They also include lead movement, a blood clot near the spinal cord, a spinal fluid leak, hardware failure, and loss of effect over time.

Adjuncts, labeled honestly. Ketogenic eating, specialized pro-resolving mediators, and photobiomodulation are add-ons and unproven for diabetic nerve damage. If you want to try one, set a fixed trial window and a stopping rule before you start. And be willing to stop if nothing changes. That is an optional add-on with a deadline. It is not treatment for your nerve damage and should not be sold to you as one.

An honest picture of what “better” looks like

The following is a composite — a picture built from many patients with this condition, not one person’s chart. Years of burning feet. Gabapentin pushed to the top dose, then duloxetine, then a tricyclic stopped early when the ECG showed a conduction delay (a slowed electrical signal in the heart). Months of work with the primary team to bring an HbA1c into range to qualify. A stimulator trial that was awkward and inconvenient, including keeping a dressing dry for a full week without a shower. In the randomized trial above, about one person in five did not reach the response goal at three months. That is exactly what the trial week exists to find out.³

In this composite, relief did come. It was large but partial. The burning quieted. Sleep came back. The numbness did not reverse — large-fiber loss does not undo itself. That is why the daily foot check went on. That is not a cure. That is a person who got their nights back and kept both feet. Individual results vary.

Frequently asked questions

The office, hours and directions are on our Locations page.

Key takeaways

• Diabetic peripheral neuropathy is a length-dependent, dying-back axonopathy. The longest nerve fibers, running from the low back to the big toe, fail at the far end first.
• Small fibers break down before large ones. That is why burning pain and dead numbness exist in the same foot. And it is why a numb foot needs a daily check to prevent an unnoticed ulcer.
• Blood sugar control has evidence for preventing new nerve damage in type 1 diabetes only. It was not statistically significant in type 2. It does not reverse existing damage, and it raises the risk of severe low blood sugar.
• Drug therapy only treats symptoms and works only while taken. The 2022 AAN guideline advises against opioids here.
• For pain that has not responded to a gabapentinoid plus one other class for a year or more, 10 kHz spinal cord stimulation has randomized evidence. But that evidence had no sham and patients knew their group. It has real device risks, and a one-week trial comes before any implant.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. If your feet burn at night, or you have stopped feeling the floor, call (314) 481-5000 or text (314) 886-5902 to arrange a full neuropathy evaluation.

References

1. Price R, Smith D, Franklin G, et al. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee. Neurology. 2022;98(1):31-43. PMID 34965987. PubMed
2. Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;2012(6):CD007543. PMID 22696371. PubMed
3. Petersen EA, Stauss TG, Scowcroft JA, et al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial. JAMA Neurol. 2021;78(6):687-698. PMID 33818600. PubMed

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP